NCT00310895 2015-12-24
Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
Geron Corporation
Phase 1 Completed
Clinical Trials
4 trialsNCT00510445 2015-12-24
Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer
Geron Corporation
Phase 1 Completed
NCT00594126 2015-12-24
Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
Geron Corporation
Phase 1 Completed
NCT00718601 2015-12-24
Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma
Geron Corporation
Phase 1 Completed